Table 1.
Baseline demographic, clinical and psychosocial characteristics of patients with type 2 diabetes
| Total | followed for one year (a) | not followed (n = 14) | ||
| Baseline variables | (n = 304) | (n = 290) | dropouts (n = 10) |
died (n = 4) |
| Demographic variables | ||||
| Sex(M/F) | 170/134 | 161/129 | 6/4 | 3/1 |
| Age (y) | 61.9 ± 11 | 61.1 ± 11 | 57.4 ± 12 | 70.5 ± 8.2 |
| Duration of illness (y) | 11.6 ± 8.1 | 11.6 ± 10 | 8.8 ± 7.2 | 14.0 ± 3.6 |
| Clinical variables | ||||
| HbA1c (%) | 7.30 ± 1.2 | 7.32 ± 1.2 | 6.72 ± 0.88 | 7.83 ± 1.3 |
| Treatment regimen (diet only/medication) | 63/241 | 59/231 | 4/6 | 0/4 |
| No. of microvascular complications of diabetes (0/1/2/3) | 116/79/60/49 | 107/77/60/46 | 9/0/0/1 | 0/2/0/2 |
| Psychosocial variables (score) | ||||
| DTSQ | 25.3 ± 6.4 | 25.2 ± 6.4 | 28.0 ± 5.5 | 26.3 ± 7.4 |
| W-BQ12 | 23.8 ± 6.7 | 23.8 ± 6.6 | 25.5 ± 8.1 | 20.0 ± 9.1 |
| PAID | 33.0 ± 21 | 33.4 ± 21 | 21.5 ± 23 | 37.2 ± 25 |
| SES | 35.2 ± 6.2 | 35.3 ± 6.2 | 32.6 ± 6.9 | 38.3 ± 5.4 |
| Social Support Scale | 56.2 ± 17 | 56.4 ± 16 | 48.1 ± 18 | 61.3 ± 22 |
| Self-Efficacy Scale | 74.0 ± 12 | 73.9 ± 12 | 75.9 ± 13 | 76.0 ± 8.8 |
Values are mean ± SD or n. Medication, oral hypoglycemic agents, or insulin, or insulin plus oral hypoglycemic agents. DTSQ, Diabetes Treatment Satisfaction Questionnaire measures satisfaction with the current therapy for diabetes; W-BQ12, Well-being Questionnaire12 measures the psychological well-being of patients with diabetes; PAID, Problem Areas in Diabetes Scale measures diabetes-specific emotional distress; SES, Self-Esteem Scale measures global self-esteem; Social Support Scale measures the degree of social support in daily life for chronic disease; Self-Efficacy Scale measures self-efficacy in dealing with health behavior in chronic disease.